
Onconova Therapeutics, Inc.
NASDAQ:ONTX
0.9953 (USD) • At close April 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||
Current Assets: | |||||||||||||
Cash & Cash Equivalents
| 20.821 | 38.757 | 55.07 | 19.025 | 22.726 | 16.97 | 4.024 | 21.4 | 19.799 | 43.582 | 60.009 | 81.527 | 2.713 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39.994 | 0 | 0 |
Cash and Short Term Investments
| 20.821 | 38.757 | 55.07 | 19.025 | 22.726 | 16.97 | 4.024 | 21.4 | 19.799 | 43.582 | 100.003 | 81.527 | 2.713 |
Net Receivables
| 0.018 | 0.029 | 0.028 | 0.037 | 0.098 | 0.035 | 0.059 | 0.031 | 1.504 | 0 | 0 | 0 | 0.478 |
Inventory
| 1.42 | 0.097 | 0.029 | 0.09 | 0.025 | 0 | 0 | 1.565 | 1.687 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0.401 | 0.464 | 0.303 | 0.632 | 0.625 | 0.76 | 0.82 | 0.073 | 0.195 | 0.387 | 4.387 | 1.725 | 0.627 |
Total Current Assets
| 22.66 | 39.347 | 55.43 | 19.784 | 23.474 | 17.765 | 4.903 | 23.069 | 23.185 | 46.905 | 104.39 | 83.252 | 3.818 |
Non-Current Assets: | |||||||||||||
Property, Plant & Equipment, Net
| 0.022 | 0.024 | 0.038 | 0.052 | 0.05 | 0.009 | 0.064 | 0.152 | 0.248 | 0.42 | 0.626 | 0.463 | 0.507 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.001 | 0.001 | 0.01 | 0.15 | 0.15 | 0.149 | 0.012 | 0.012 | 0.012 | 0.012 | 0.137 | 0.137 | 0.137 |
Total Non-Current Assets
| 0.023 | 0.025 | 0.048 | 0.202 | 0.2 | 0.158 | 0.076 | 0.164 | 0.26 | 0.432 | 0.763 | 0.6 | 0.644 |
Total Assets
| 22.683 | 39.372 | 55.478 | 19.986 | 23.674 | 17.923 | 4.979 | 23.233 | 23.445 | 47.337 | 105.153 | 83.852 | 4.462 |
Liabilities & Equity: | |||||||||||||
Current Liabilities: | |||||||||||||
Account Payables
| 5.619 | 3.86 | 2.757 | 4.833 | 4.271 | 4.039 | 6.186 | 5.323 | 3.421 | 4.027 | 3.71 | 5.517 | 5.614 |
Short Term Debt
| -3,374,996.625 | 0 | 0 | 0 | 0 | 4.16 | 0 | 4.184 | 3.723 | 5.772 | 5.436 | 3.768 | 1.982 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.018 | 0.302 | 0 | 0 |
Deferred Revenue
| 0.226 | 0.226 | 0.226 | 0.226 | 0.226 | 0.226 | 0.455 | 0.455 | 0.455 | 0.455 | 0.788 | 3.907 | 0.455 |
Other Current Liabilities
| 3,375,000 | 3.96 | 3.132 | 4.962 | 3.795 | 0.013 | 3.335 | 0.198 | 0.006 | -0.013 | 0.102 | 12.186 | 4.03 |
Total Current Liabilities
| 9.22 | 8.046 | 6.115 | 10.021 | 8.292 | 8.438 | 9.976 | 10.16 | 7.605 | 10.259 | 10.338 | 25.378 | 12.081 |
Non-Current Liabilities: | |||||||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 2.791 | 3.017 | 3.243 | 3.469 | 3.695 | 3.922 | 4.091 | 4.545 | 5 | 13.455 | 13.909 | 15.421 | 10.718 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0.321 | 0.113 | 0.176 | 1.773 | 3.401 | 0 | 0.001 | 0.006 | 0.044 | 120.082 |
Total Non-Current Liabilities
| 2.791 | 3.017 | 3.243 | 3.79 | 3.808 | 4.098 | 5.864 | 7.946 | 5 | 13.456 | 13.915 | 15.465 | 130.8 |
Total Liabilities
| 12.011 | 11.063 | 9.358 | 13.811 | 12.1 | 12.536 | 15.84 | 18.106 | 12.605 | 23.715 | 24.253 | 40.843 | 142.881 |
Equity: | |||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 105.153 | 0 | 0 |
Common Stock
| 0.21 | 0.209 | 0.209 | 1.859 | 1.112 | 0.057 | 0.108 | 0.068 | 0.255 | 0.217 | 0.215 | 0.154 | 0.022 |
Retained Earnings
| -482.631 | -463.683 | -444.719 | -428.556 | -403.399 | -381.896 | -362.316 | -338.224 | -318.557 | -294.578 | -230.896 | -168.353 | -138.441 |
Accumulated Other Comprehensive Income/Loss
| -0.023 | -0.033 | -0.014 | 0.014 | -0.018 | -0.012 | 0.003 | -0.031 | -0.022 | -0.013 | 0.001 | -1.348 | -1.131 |
Other Total Stockholders Equity
| 493.116 | 491.816 | 490.644 | 432.858 | 413.879 | 387.238 | 350.514 | 342.484 | 328.334 | 317.122 | 205.94 | 212.556 | 1.131 |
Total Shareholders Equity
| 10.672 | 28.309 | 46.12 | 6.175 | 11.574 | 5.387 | -11.691 | 4.297 | 10.01 | 22.748 | 80.413 | 43.009 | -138.419 |
Total Equity
| 10.672 | 28.309 | 46.12 | 6.175 | 11.574 | 5.387 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities & Shareholders Equity
| 22.683 | 39.372 | 55.478 | 19.986 | 23.674 | 17.923 | 4.979 | 23.233 | 23.445 | 47.337 | 105.153 | 83.852 | 4.462 |